Henry Schein, Inc. HSIC
Verdict: Sell. Fair value $72.76 against a price of $78.54 on 6 Jan 2026, 7% below the price.
In plain words
The case for: Narrow competitive moat provides durability. Market leadership enables pricing power. Industry tailwinds with growing market.
The case against: Intense competitive pressure could compress margins. Net Income has declined for three consecutive years, from a peak of $0.62B in 2021 to $0.39B in.... The company has a 50% earnings beat rate over the last four quarters with an average surprise of....
Main risks
- Steeply Declining Profitability: Net income has fallen for three consecutive years, from $0.62B in 2021 to $0.39B in 2024, indicating severe margin compression.
- Stagnant Revenue Growth: After a post-pandemic rebound, revenue has been essentially flat since 2021, suggesting market share loss or pricing pressure.
- Poor Capital Allocation & Missing Data: Proxy ROIIC is highly negative (-30.2%), suggesting recent investments have destroyed value. The absence of debt data makes a full risk and return-on-capital assessment impossible.
- Net Income has declined for three consecutive years, from a peak of $0.62B in 2021 to $0.39B in...
- Intense competitive environment
- Net Income has declined for three consecutive years, from a peak of $0.62B in 2021 to $0.39B in 2024, a 37% drop. This occurred while revenue remained relatively flat to slightly increasing ($12.40B in 2021 to $12.67B in 2024), suggesting significant margin compression or rising operating costs.